Skip to main content

Table 5 Differences in prescribed drugs for women in different BMI-categories: bivariate and multilevel analyses

From: Moderately overweight and obese patients in general practice: a population based survey

  Bivariate analyses a) Percentage that got prescribed for ICPC-chapter Multilevel logistic regression b,c)
Adjusted odds ratios [95% BI]
ATC-Chapter BMI < 25 kg/m2
(n = 1980)
BMI 25- <30 kg/m2
(n = 1707)
BMI = 30 kg/m2
(n = 361)
  BMI 25- <30 kg/m2 BMI ≥ 30 kg/m2
Alimentary tract and metabolism (A) 16.7 23.4 30.4 p < 0.001 1.13 [0.96–1.34] 1.53* [1.24–1.90]
Blood and blood forming organs (B) 9.0 11.7 15.5 p < 0.001 0.90 [0.72–1.12] 1.16 [0.88–1.54]
Cardiovascular system (C) 15.1 28.8 37.8 p < 0.001 1.58* [1.33–1.88] 2.53* [2.02–3.16]
Dermatologicals (D) 23.4 24.5 32.4 p < 0.001 1.00 [0.85–1.16] 1.45* [1.18–1.77]
Genito urinary system and sex homones (G) 37.9 28.7 26.5 p < 0.001 1.03 [0.88–1.21] 0.87 [0.70–1.09]
Systemic hormonal preparations (H) 5.4 8.4 10.7 p < 0.001 1.23 [0.95–1.58] 1.53* [1.12–2.11]
Antiinfectives for systemic use (J) 28.9 36.9 42.1 p < 0.001 1.11 [0.96–1.28] 1.35* [1.12–1.64]
Antineoplastic and immunomodulating agents (L) 0.8 0.9 1.5 ns 0.97 [0.48–1.97] 1.61 [0.72–3.60]
Musculoskeletal system (M) 20.6 29.6 36.0 p < 0.001 1.38* [1.18–1.60] 1.75* [1.43–2.14]
Nervous system (N) 26.1 33.1 35.0 p < 0.001 1.09 [0.94–1.26] 1.15 [0.94–1.40]
Antiparasitic products (P) 1.5 0.9 1.5 ns 0.72 [0.39–1.35] 0.94 [0.41–2.16]
Respiratory system (R) 20.9 25.1 31.1 p < 0.001 1.23* [1.05–1.44] 1.62* [1.33–1.99]
Sensory organs (S) 9.7 11.6 11.8 ns 1.04 [0.85–1.29] 1.03 [0.78–1.38]
  1. a) significance test: Pearson Chi-square test, ns= not significant (p < 0.05), ns = not significant (p > 0.05)
  2. b) Multilevel logistic regression, odds ratios are corrected for age, sex, educational level, type of health insurance, residence, smoking, alcohol consumption and exercising
  3. c) reference in logistic regression is BMI < 25
  4. * p < 0.05